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Anuradha Valiya Kambrath 
TESTING THE RELIABILITY AND SELECTIVITY OF DIFFERENT BONE-CELL 
-SPECIFIC CRE-EXPRESSING MOUSE MODELS FOR STUDYING BONE 
CELL METABOLISM 
 
The Cre/loxP system is a tool for targeted recombination of DNA. For applying 
Cre recombinase-mediated genome modifications, there is a requirement for 
reliable, high-fidelity, and specific transgenic expression of the Cre recombinase. 
This study focuses on the reliability of different bone cell specific Cre models in 
the Cre/loxP system. In this study, DMP1-Cre transgenic mouse which has a 
transgene driven by DMP1 promotor that allows Cre-expression only in late stage 
osteoblasts and osteocytes was used. Ctsk-Cre mouse with a driven by Ctsk 
promoter was used so that only osteoclasts would undergo Cre-mediated 
recombination. E2A-Cre mouse where the Cre recombinase is driven by a global 
promoter E2A was also included in this study as a control line to test the Cre 
reporter line Ai9. Dmp1-Cre, Ctsk-Cre and E2A-Cre mice were crossed to the 
fluorescent Cre-reporter line—Ai9, which harbors a floxed stop codon, followed 
by the fluorophoremTomato, inserted into the Rosa26 locus. This construct is 
expected to give red fluorescence when it recombines with Cre-expressing 
mouse cells and no fluorescence in non-recombinant mouse cells. Double 
positive (Ai9+/Cre+) offspring selected by PCR were perfused, and 5µm thick 
section of bone and soft tissues were examined for red fluorescent expression. 
Cre positive cells were quantitated using ‘ImageJ’ software program. The DMP1-
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Cre mouse results showed significant expression in the targeted osteocytes and 
osteoblasts. In addition, skeletal muscle tissue also showed significant Cre- 
expression. Ctsk-Cre mice showed significant expression in targeted osteoclasts. 
But brain tissue was positive in Cre-expression. Bone-Cre mouse models are 
expected to express Cre recombinase only in their respective bone cells and they 
have been used for gene deletion studies in bone cells. However, this study has 
revealed that the bone cell specific Cre mouse models DMP1-Cre and Ctsk-Cre 
have unexpected expression in muscle and brain respectively. In order to use 
these models for targeted gene deletion in bone cells, further testing and studies 
have to be conducted.  
Robling G Alexander, Ph.D., Chair 
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1. Background 
 
Aim:  
To determine the tissue specificity and reliability of different Cre-expressing 
mouse models, to better understand the body-wide (off-target) effects of floxed 
gene recombination in ‘bone-specific’ models of Cre expression.   
 
Genetic mouse models are valuable tools for scientific research and discovery. 
Deletion of a specific gene could reveal role of a particular protein or even the 
entire signaling pathway involved in disease and health. Thus genetic deletion 
has become a relatively straight forward and routine practice in biomedical 
sciences. However, there are limitations for conventional gene knockout 
strategies which made them difficult to apply in research contexts. Conventional 
(germ line) knockout can produce a lethal phenotype, precluding the study of that 
gene or pathway in a postnatal system. Also certain genes can have diverse 
effects across tissues, so it is difficult to study the effect of genetic deletion on the 
phenotype in the context of an isolated tissue or organ system. The Cre/loxP 
system is a tool that has been developed to solve some of these problems and it 
has expanded our ability to conduct studies.  
 
1.1. Cre/loxP system: 
The Cre/loxP system is a tool for site specific recombination of DNA. This 
 
recombination system is originated from lytic cycle of P1 bacteriophage in E coli. 
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Cre/loxP recombination is a natural process that occurs in the life cycle of P1 
bacteriophage which plays two important roles. The first role involves 
circularization of P1 DNA when it enters the host.10-20% of P1 DNA is terminally 
redundant and some of the entering P1 DNA molecules contain two loxP sites 
and can be efficiently circularized by Cre. The second role involves the 
breakdown of dimer P1 DNA molecules that may form as a result of replication or 
homologous recombination [1]. When a DNA containing the loxP site is incubated 
with Cre, a specific cleavage occurs within the spacer region, creating a six base-
pair staggered cut. The cuts are centered on the axis of dyad symmetry of 
the loxP site, resulting in a 5′ protruding terminus: 5′ A↓T-G-T-A-T-G C/ 3′ T A-C-
A-T-A-C↑G At the point of cleavage, Cre becomes covalently attached to a 3′ 
PO4, and produces a free 5′ OH [2]. The Cre/loxP system is functional in both 
bacteria and eukaryotic cells and has been used for the excision and the 
integration of fragments in cellular and viral genomes. It has been exploited in 
cell-free systems for construction of recombinant vectors [3]. This system is also 
useful for genetic knockout or knock-in in animal models when a conventional 
knockout produces (a) lethal phenotype, or (b) when conventional knockout is 
viable but tissue-specific effects are desired [5].  In vivo, two mouse lines are 
required for conditional gene deletion using the Cre/loxP system. The first mouse 
model required is one that expresses the coding sequence for Cre transgene, 
under the control of a promoter that has the desired tissue or cell-type selectivity. 
Cre is a tyrosine recombinase isolated from the P1 bacteriophage, which 
recognizes and cleaves the 34 base pair loxP sequence. The second mouse 
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model harbors a modification of the gene of interest, such that a crucial portion of 
the coding sequence is flanked by loxP sequences, which resides in the non-
coding introns. This gene, once the loxP sequences are introduced, is said to be 
‘floxed’. The introduction of loxP sequences into the intronic regions does not 
have an effect on target gene transcription [5, 6, 7]. Recombination (excision and 
consequently inactivation of the target gene) occurs only in those cells 
expressing Cre recombinase. Hence, the target gene remains active in all cells 
and tissues which do not express Cre [4, 5].  
 
1.2. Cre recombinase: 
The Cre recombinase is an integrase family of enzyme derived from P1 
bacteriophage [5]. This enzyme is a tyrosine recombinase and catalyzes the site 
specific recombination of DNA between two loxP sites. The enzyme does not 
require any co-factors and Cre-mediated recombination quickly reaches 
equilibrium between substrate and products. The loxP recognition element is a 
34 bp sequence which has 13 bp inverted repeats flanking an 8 bp spacer region 
which is for directionality (Figure 1) [1, 3, 4]. Recombination products depend on 
the location and relative orientation of the loxP sites. Two DNA fragments 
containing single loxP sites will be fused, DNA between directly repeated loxP 
sites will be excised in circular form and DNA between opposing loxP sites will be 
inverted with respect to external sequences [6]. Cre recombinase is one of the 
important tools that have made many of the genome alteration technologies 
possible.  
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Figure 1: Schematic illustration of Cre/loxP system (from reference 5). (a) Close-up of Cre 
recombinase-mediated recombination between two 34 bp loxP sites. Nucleotide exchange occurs 
in between the two loxP sites.  (b) When the loxP sequences are in direct repeat, deletion occurs. 
(c) When the two lopxP sequences are in inverted repeats, inversion occurs. 
 
 
For applying Cre recombinase-mediated genome modifications, there is a 
requirement for reliable, high-fidelity and specific transgenic expression of the 
Cre recombinase. Cre mouse models may not give expected result since many 
of them are prone to ectopic expression, transgene silencing or genetic 
background effects [8]. Experimental validation of the Cre line is essential and 
can be achieved through a combination of molecular and immunohistochemical 
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approaches. The aim of this study is to test the reliability of different bone cell 
specific Cre mouse models when they are recombined with floxed genes, so that 
they could be used as a valuable tool for studying bone cell metabolism.  
 
1.3. Bone cells and bone metabolism: 
Bone tissue is maintained by three primary cell types: Osteoblasts, osteocytes 
and osteoclast. Osteoblasts are bone-forming cells, which are derived from 
mesenchymal progenitors [9]. The main function of the osteoblast is bone matrix 
protein secretion and bone mineralization. After completion of bone matrix 
formation, some mature osteoblasts remain entrapped in bone matrix as 
osteocytes, some flatten to cover quiescent bone surfaces as bone lining cells 
and the rest die by apoptosis [10]. Osteocytes or mature bone cells are former 
osteoblasts that have migrated into, and become trapped and are surrounded by 
bone matrix. They are regularly distributed throughout the mineralized bone 
matrix. Osteocytes are the major population of cells in bone. They comprise more 
than 90% of the cells within the matrix or on the surface and they coordinate the 
function of osteoclasts and osteoblasts [10]. Osteoclasts are the cells responsible 
for bone resorption [9, 11]. They have major role in bone modeling which 
changes the shape of bone during growth, and bone remodeling which maintains 
the integrity of adult skeleton [10]. Bone is highly dynamic organ that undergoes 
significant turnover compared to the other organs in the body. Bone remodeling 
consists of two main process, bone formation and bone resorption which are 
tightly coupled. Loss of balance between these will cause diseases such as 
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osteoporosis, osteopetrosis and osteosclerosis. Complex intracellular signaling 
pathways are involved in bone metabolism, and regulation of balance between 
the osteoprogenitor cells, mature osteoblasts, osteocytes and osteoclasts [19].  
 
 Each bone cell types has a characteristic gene expression profile, and some 
genes are specific to each. The selectivity of gene expression allows the use of 
specific promoters to drive Cre-expression (via transgenesis) in particular 
subtypes of bone cells. For example, dentin matrix protein1 (DMP1) is expressed 
by osteocytes and some late stage osteoblasts. DMP1 regulates cell attachment 
and cell differentiation, activates matrix metalloproteinase-9 and affects bio 
mineralization [12, 13, 4]. In this study, I used the DMP1-Cre transgenic mouse 
which has a DMP1 promoter that drives Cre recombinase expression only to late 
stage osteoblasts and osteocytes. Therefore these cells would be expected to 
undergo Cre-mediated recombination.  
 
1.4. DMP1-Cre mouse line: 
The generation of DMP1-Cre mouse has been reported previously [20]. Briefly, 
the mouse DMP1 promotor used in these experiments was a 14-kb fragment of a 
full length promotor that contains a 9624- bp promotor region, a 95-bp exon 1, a 
4626-bp intron I and a 17-bp initial non coding region of exon II. This fragment 
was sub cloned into the Xhol site of pMHCre vector which contains the Cre 
cDNA. The 15.0-kb DMP1-Cre transgene was then released from vector 
backbone with the use of restriction enzyme Pme1 and purified. The transgene 
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was microinjected into the pronuclei of fertilized mouse eggs isolated from CD-1 
outbred mice. The surviving eggs were transferred into oviducts of 
pseudopregnant CD-1 recipient mice for generation of the transgenic mice [20].  
                   
To determine whether the recombination has occurred, I crossed DMP1-Cre 
mouse to a fluorescent Cre-reporter line- Ai9. 
 
Ctsk is a gene whose expression is strong in the osteoclast. Cathepsin K (Ctsk) 
is a cysteine protease upregulated during osteoclastogenesis and is expressed in 
the mature osteoclast [15]. I used the Ctsk-Cre mouse where Ctsk promoter 
drives Cre recombinase expression, so that presumably only osteoclasts would 
undergo Cre-mediated recombination. 
 
1.5. Ctsk-Cre mouse line: 
The generation of Ctsk-Cre mouse used in this study has been reported 
previously [21]. Briefly, the plasmid -pGL3-CK5.0 containing nucleotides 3350 to 
1660 of the Ctsk gene in a pGL3 vector were modified using standard restriction 
digestion and cloning techniques to include the Cre coding sequence and 
generate the Ctsk-Cre construct. The Ctsk-Cre fragments were excised and 
separated from the plasmid by restriction digestion and agarose gel 
electrophoresis. The constructs were purified and microinjected into the pronuclei 
of fertilized oocytes. Surviving eggs were transferred into pseudopregnant female 
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mouse. PCR was performed with the tail genomic DNA using primers to confirm 
the presence of the Ctsk-Cre gene [21]. 
 
To determine whether the recombination has occurred, I crossed the Cre- 
expressing mice to the same fluorescent Cre-reporter line—Ai9. 
 
1.6. Ai9 reporter line: 
Ai9 is a transgenic Cre reporter mouse line that expresses red fluorescent 
marker when loxP recombination has occurred. Several Cre mediated studies 
have been reported in which the lacZ gene is turned on in cells by Cre 
recombinase. The advantage of fluorescent reporter over the conventional the 
lacZ reporting system is that the former does not requires substrate addition step 
as does the lacZ method. Also, the bright fluorescent color can be easily 
visualized in positive cells. In the Ai9 fluorescent reporter mouse the ubiquitously 
expressed Rosa 26 locus is used to express the tomato reporter. The Rosa 26 
locus is modified by insertion of a construct containing a ubiquitous CAG 
promotor, a floxed stop codon followed by the flourophorem tdTomato which 
encodes a red fluorescent protein (Figure 2). In these mice, the transgene 
produces no transcript because of the functional (floxed) stop codon that 
precedes tomato. When Cre is introduced into the cell, Cre recombines the loxP 
sites that surround the stop sequence deleting the stop so the cell can transcribe 
the tomato allele [15]. Thus, this mouse “reports” via a bright red signal, the cell 
in which recombination has occurred. Cells in which no recombination has 
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occurred do not fluoresce red. Here, the Ai9 reporter model allows us to test the 
reliability, cell-specificity, off-target effects, and timing of different Cre mouse 
models that are used for bone genetic studies in mouse models.  
 
 
Figure 2 (from reference 15): Schematic diagram of Ai9 construct. It contains a CAG 
promoter, a floxed stop sequence, the red fluorescent protein tdTomato, Woodchuck hepatitis 
post-transcriptional regulatory element (WPRE) for high level expression, and other elements 
such as PA, AttB, Pr, Frt and Neo for plasmid integration and positive cell selection. 
                 
To test if the Ai9 reporter interferes with any genes or other factors in the bone-
Cre models to give false positive or false negative results, I tested the Cre- 
expression of a global Cre-expressing mouse –E2A-Cre when recombined with 
Ai9. The E2A-Cre carries a Cre transgene under the control of an adenovirus 
E2A promoter, a ubiquitous promoter that can drive Cre- expression in a wide 
range of tissue/cells in mouse [38]. The E2A product is an activator of many B 
cell specific genes. 
 
1.7. E2A-Cre mouse line: 
The generation of E2A-Cre mice used in this study has been reported previously 
[25]. Briefly, the E2A plasmid was constructed by replacing the human 
cytomegalovirus promotor in pBS 185 with the adenovirus promoter from pEII-
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lacZ. This construct was microinjected into mouse zygote for production of 
transgenic mouse [25].  
 
The Cre mouse models included in this study and their cell type targets are listed 
in Table 1.  
 
 
Cre mouse lines 
 
Targeted Tissue/cell 
 
DMP1-Cre 
 
Osteoblast and osteocytes 
 
Ctsk-Cre 
 
Osteoclast 
 
E2A-Cre 
 
All cell type/tissue type 
 
Table 1: Cre mouse lines used in this study. 
 
Ai9 mouse line was crossbred with all the above listed ‘bone –Cre’ lines. Double 
positive offspring were selected by molecular biology methods for further studies. 
To study Cre-mediated recombination in bone and other tissues of the mice, I 
applied various histological methods and fluorescent microscopic analysis.  
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2. Research Methods 
 
2.1. Generation of mice that harbor Ai9 transgene, and Cre transgene:  
The Ai9 reporter mouse line, B6.Cg-Gt (ROSA) 26Sortm9 (CAG-tdTomato)   /J strain 
was purchased from ‘the Jackson laboratory’. The DMP1-Cre transgenic mouse 
line was a gift from Jerry Feng [20]. The Ctsk-Cre transgenic mouse line was a 
gift from W S M Chiu [21]. The E2A-Cre transgenic mouse line was also a 
commercial line purchased from ‘the Jackson laboratory’.  
 
Homozygous Ai9 male (Male mice are homozygous for Ai9 gene) mice were 
mated with hemizygous E2A-Cre, DMP1-Cre and, Ctsk-Cre mice to obtain Ai9 
positive mice that were positive or negative for Cre. PCR was performed to select 
the Ai9 and different Cre double positive mice. Three mice samples of 4-6 weeks 
old from each Cre lines were studied during the time period of June 2013-
October 2014. The mice samples included both males and females.  
 
2.2. DNA extraction and PCR: 
Samples of ear tissue from mice were used to extract DNA. Ear notching was 
also helpful to tag, identify and differentiate mice in each cage. Animals in each 
cage were ear punched using an ear punch device and the ear pieces were 
collected using forceps. The ear notching tools were cleaned after handling each 
mice using 70% alcohol solution. Mice were differentiated as right front (RF), 
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right rear (RR), left front (LF) and left rear (LR) based on where the ear was 
notched.  
 
PCR was performed using HotSHOT (Hot Sodium Hydroxide and Tris) reagents. 
HotSHOT lysis reagent is an alkaline solution (pH 12) prepared with 25 mM 
NaOH and 0.2 mM disodium EDTA. The solution was prepared by dissolving the 
salt in water without adjusting the pH. HotSHOT neutralization reagent is 40mM 
Tris-HCl with a pH 5, and was prepared by dissolving Tris-HCl in water without 
adjusting the pH. The ear tissue samples were collected in thermal cycler strip 
tubes. 75uL of the alkaline lysis reagent was added to the tubes and heated to 
95ºC for 10 minutes to 1 hour and then cooled to 4ºC in the PCR cycler.  75 uL 
neutralizing reagent was added to each sample tubes immediately. 3 uL of the 
DNA sample was added to 12 uL of the PCR mixture. PCR mixture has 7.5 uL of 
RED PCR mix, 0.35 uL of each primers (20uM stock), and 3.45 uL of PCR grade 
water (Promega, Madison, WI, USA). The tubes were placed in PCR cycler for 
the following thermo cycling procedure: Reactions were held at 94ºC for 3 
minutes for initial denaturing, 30 seconds for denaturing, 60ºC for 30 seconds for 
annealing, 72ºC for 1 minute for extension (35 cycles of denaturing, annealing 
and extension) and at 72ºC for another 10 minutes for final extension. Tubes 
were held at 4ºC for 40 cycles at 95ºC for 40 seconds and 60ºC for 45 seconds.  
Following amplification, 7-10uL of the PCR product was added to each well of a 
2.2% agarose gel placed horizontally in an electrophoresis chamber. TAE (0.5X0 
was used as the loading buffer. Electrophoresis was performed at 100 V for 45 
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minutes in 1X TBE buffer (89mM Tris/89mM boric acid, 2mM EDTA). Gels were 
imaged under the UV light trans-illuminator and images were taken [33]. 
 
2.2.1. PCR to test Ai9 positive mouse: 
DNA extract was added into PCR mix solution containing master mix, DNase free 
water and the 4 Primers, 1. oIMR9020: 5’- AAG GGA GCT GCA GTG GAG TA – 
3’, 2. oIMR9021: 5’- CCG AAA ATC TGT GGG AAG TC, 3. oIMR9103: 5’- GGC 
ATT AAA GCA GCG TAT CC- 3’, 4. oIMR9105: 5’- CTG TTC CTG TAC GGC 
ATG G- 3’. PCR products were analyzed for positive Ai9 transgene of band size 
196 bp, and the control Rosa-26 gene of 297 bp by running agarose gel 
electrophoresis at 100V for 45 minutes.  
 
 2.2.2. PCR to test DMP1-Cre positive mouse: 
 Using ear tissue sample from the mice, DNA was extracted by the same method      
described in method 2.2. As described in method 2.2.1, PCR was performed but 
using different primers, 1. 5’-CCG GGC TGC CAC GAC CAA GT – 3’, 2. 5’- GCG 
CGAGTT GAT AGC TGG CTG GT -3’, 3. 5’-AAA GTC GCT CTG AGT TGT TAT 
-3’, 4. GGA GCG GGA GAA ATG GAT ATG. Primers 1 and 2 are for DMP1-Cre 
forward and reverse sequence, and 3 and 4 are for internal control Connexin-43 
wild type forward and reverse. PCR products were analyzed for positive DMP1-
Cre gene of band size 529bp and the Connexin-43 of 1000bp by running agarose 
gel electrophoresis at 100V for 45 minutes. 
 
  
14 
 
2.2.3. PCR to test Ctsk-Cre positive mouse: 
DNA was extracted from the ear notch sample applying the same procedure 
given in method 2.2. PCR was performed as described in method 2.2.1, but 
different set of primers, 1. 5’- GAG TGA TGA GGT TCG CAA GA-3’, 2. 5’ CTA 
CAC CAG AGA CGGAAATC-3’, 3.5’-TCATGCCCGGCACAAGTGAGAC-3, 
4.5’TCACCCCAAGCTGACTCAACCG-3’. 1 and 2 are primers for Ctsk-Cre 
forward and reverse, and 3 and 4 are for internal control connexin-43 forward 
and reverse sequence. PCR products were analyzed for a 600 bp Ctsk-Cre band 
and 1000 bp Connexin-43 band by running agarose gel electrophoresis at 100V 
for 45 minutes. 
 
2.2.4. PCR to test E2A-Cre positive mouse: 
DNA was extracted from ear notch samples by the same procedure described in   
method 2.2. PCR was performed with the extracted DNA sample by following 
the procedure in method 2.2.1, but using different set of primers. 1. oIMR1084: 
5’- GCG GTC TGG CAG TAA AAA CTA TC – 3’, 2. oIMR1085: 5’- GTG AAA 
CAG CAT TGC TGT CAC TT- 3’, 3. oIMR7338: 5’- CTA GGC CAC AGA ATT 
GAA AGA TCT – 3’, 4. oIMR7339: 5’- GTA GGT GGA AAT TCT AGC ATC ATC 
C – 3’. Primers 1 and 2 are for E2A-Cre transgene forward and reverse, and 3 
and 4 are for forward and reverse band of internal control IL-2 gene. PCR 
products were analyzed for 100bp E2A-Cre transgene band and 324 bp IL-2 
internal control band by running agarose gel electrophoresis at 100V for 45 
minutes 
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2.3. Perfusion and collection of organs from mice: 
The Ai9, Cre - double positive mice were subjected to anesthesia by giving 
isoflurane inhalation. The pinch-response method was used to confirm that the 
animal was under deep anesthesia. An incision was made with scalpel through 
the abdomen along the length of diaphragm. With sharp scissors the body was 
cut through the connective tissue at the bottom of the diaphragm to reach the rib 
cage. The thoracic cavity was clamped open with a chest retractor to expose the 
heart. The heart was held steady with forceps, and needle was inserted into 
protrusion of left ventricle straight up about 5mm. 4% PBF solution was perfused 
into the organs. The body was cut open and femur bones and different organs 
such as liver, kidney, spleen, duodenum, heart and brain were collected in 4% 
PBF. 
 
2.4. Freeze-embedding of the sample: 
The femur bone and the other different tissue samples were rapidly frozen in -
72ºC cold N-Hexane in order to minimize freezing artifacts. Each of the freshly 
frozen samples (positive and negative) were placed in a rectangle shaped 
stainless steel container filled with OCT. The OCT containing tissue samples 
were completely frozen by keeping the metal block in the cold N- Hexane. The 
frozen block was stored at -80ºC until further analysis. 
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2.5. Cryosectioning:  
The frozen OCT block was fixed to a circular disc with OCT gel and then placed  
on the stage of a cryomicrotome. The block was trimmed to expose the tissue to 
the surface of block. The adhesive film purchased from Japan [18] was cut so as 
to have the same width of the block and was adhered to the cutting surface of the 
block.  5 µm thick sections were collected on the adhesive film by cutting the 
block along with the film slowly at a constant speed. Two contiguous sections 
were collected, one for fluorescent cell analysis and the other for stained cell 
analysis [18]. 
 
2.6. Staining of the tissue: 
The film containing tissue sample was washed immediately in absolute alcohol 
followed by water to remove the OCT. For fluorescent analysis, the tissue was 
stained with a DAPI solution (7ul in 15ml of water) for 2 minutes. The second 
section was stained with 0.1% toluidine blue for 30 seconds for light microscopic 
analysis. Excess stain was removed with water. The tissue sections were 
mounted by placing the section side of the adhesive film on a glass slide coated 
with SCMM mounting medium. The excess mounting media was carefully wiped 
off using a filter paper. 
 
2.7. Microscopic analysis:  
For analyzing fluorescent expression, the tissue sections were observed under 
fluorescent microscope using a filter for Texas Red by means of a program 
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‘Osteomeasure’. The cells were observed at 20X magnification and images of 
different fields of each sample were captured and saved. The same field of each 
fluorescent picture was found in the stained section under white light to match 
and sort cells, and the images were captured. Images of all different bone tissues 
and soft tissues (both positive and negative) were taken in this manner.  
 
2.8. Measuring the Cre-expression: 
In order to study whether there is significant Cre-expression in each tissue of the 
mice, the percentage of positive fluorescent cell was calculated by measuring the 
number of positive red fluorescent cells over the total number of cells (DAPI-
stained nuclei) in the tissues. The total number of cells from each tissue sample 
was counted by ImageJ-automated counting software tool and the red positive 
cells were counted manually. Tissue samples from three different DMP1-Cre and 
Ctsk-Cre mice were analyzed for fluorescent mediated Cre recombinase 
expression. Standard deviation was calculated from the average of the 
percentage of positive Cre-expressed cells from the three mice. 
 
2.9. Cell counting using ImageJ: 
ImageJ is a public domain Java image processing and analyzing program. It can 
be used to calculate area and pixel value statistics of images of user defined 
selections. There are vast repertoire of plugins available that extend ImageJ’s 
functionality beyond its basic core to make it a powerful program. ImageJ 
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provides a cost effective and reliable way to count fluorescent labelled cells. It is 
a free software which can be downloaded from internet [34, 37]. 
 
2.10. Automated counting of entire cells in an image: 
Since there are large number of cells present in each field of the tissue sections 
manual counting is not practical. Automated counting was adapted to count the 
DAPI stained nuclei of entire cells present in different fields of soft tissue that 
don’t  require additional plugin. The image to be counted was opened in the 
ImageJ software. The colored image was converted to grey scale by selecting 
Image-> Type-> 8-bit to convert grey scale. Once the image was in grey scale, 
Image-> Adjust-> Threshold, was used to highlight all the cells to be counted. 
The sliders were used to highlight the cells. Some nuclei were merged together. 
To cut them apart, Process-> Binary-> Watershed was used. Once the binary 
image of the particle was ready, Analyze-> Analyze particle was used [35]. 
 
2.11. Counting cells in a region of interest: 
To count the cells in different regions of bone tissue (marrow, matrix) separately, 
an ITCN (Image-based Tool for Counting Nuclei) plugin of ImageJ which enables 
the count of nuclei in a selected region of interest was adopted. Here the inputs 
were: (1) an estimation of diameter of a nucleus, (2) an estimation of the 
minimum distance between nuclei and (3) the region of interest selected with 
ImageJ’s area selection tool. ITCN plugin version 1.6 was downloaded for this 
purpose. The image was opened in ‘ImageJ’, converted to 8-bit. The ITCN plugin 
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was opened and the width was entered into the text field. The width is the 
approximate diameter of the cells to be counted and its value was determined 
using the selection tool to draw a line that is the diameter of a cell, and pressing 
the adjacent ‘Measure line length’. The minimum distance was entered into the 
text field. The minimum distance is the approximation of the distance between 
nuclei centers. Its value was also determined using the line selection tool and 
pressing ‘Measure line length’. The threshold was entered into text field or using 
adjacent slide bar. The threshold determines the quality of detected cells. A 
region of interest was selected using ImageJ selection tool, and ‘count’ was used 
[36]. 
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3. Results 
3.1. PCR result showing the presence of Ai9 transgene: 
PCR was performed with ear tissue samples to detect the presence of Ai9 
transgene in the offspring of the Ai9 positive male and different Cre positive 
female breeders, using respective primers. The gel was analyzed for the 
presence of 196 bp band of Ai9 transgene and 297bp Rosa26 band of internal 
control wild type Ai9 gene. Figure 3 shows PCR followed by agarose gel 
electrophoresis from Ai9 mice tissue.  
  
 
 
Figure 3: Agarose gel showing the Ai9 band. The first lane shows the DNA ladder. The second 
and third lanes show 2 bands. The high band that aligns with 300 bp is the wild type Ai9 (Rosa-
26) and the low band that aligns with 200 bp is Ai9 transgene. 
 
 
 
 
 
  
21 
 
3.2. PCR results showing the presence of E2A–Cre transgene: 
PCR was performed with ear tissue samples to detect the presence of E2A-Cre 
transgene in the offspring of the Ai9 positive male and E2A-Cre positive female 
breeders, using respective primers. The gel was analyzed for the presence of 
100 bp band of E2A-Cre transgene and 324bp band of internal control IL-2. 
Figure 4 shows PCR followed by agarose gel electrophoresis from E2A-Cre mice 
tissues.    
 
 
  
 
Figure 4: Agarose gel showing the E2A-Cre band. The first lane shows the DNA ladder. The 
second lane is a negative sample which shows only internal control band IL2 that aligns with 
300bp band of the ladder. The third lane shows 2 bands. The high band that aligns with 300 bp 
band of the ladder is the internal control IL-2 and the low band that aligns with 100 bp is E2A-Cre 
transgene.   
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3.3. Fluorescent microscopic and qualitative analysis results of the bone 
tissues from the E2A-Cre mice: 
To determine if there is Cre-mediated recombination in the bone tissue of E2A-
Cre mouse line, the Ai9 mice were crossbred to the E2A-Cre mice. The double 
positive (Ai9+/E2A-Cre+) offspring were perfused and 5 um thick sections of the 
femur bone tissue were prepared for histological analysis. The bone tissue 
sections were stained with DAPI.  Figure 5 shows the fluorescent microscopic 
images (left) and toluidine blue stained white light images (right) of bone tissue 
from an E2A-Cre positive mouse. Figure 6 shows bone tissue from an E2A-Cre 
mouse without DAPI nuclear staining. Figure 7 shows the picture of bone tissue 
from a negative E2A-Cre mouse. The skeletal muscle, osteoclast, osteoblast and 
majority of the osteocytes show red fluorescent signal which indicates the 
presence of Cre recombinase in these tissues. However the marrow cells show 
no red fluorescence which indicates that Ai9 is not reporting fluorescence in the 
bone marrow. The results show that Ai9 is successful as a Cre reporter line in 
bone. Since it represses fluorescence in bone marrow of E2A-Cre mouse line, it 
is unlikely that we will be able to determine if there is Cre-mediated 
recombination happening in this compartment in the bone-Cre mouse models. 
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Fluorescence                                            White light (toluidine blue) 
 
Figure 5: Microscopic images of bone tissue from an E2A-Cre positive mouse (DAPI 
stained). Fluorescent (left) and toluidine blue stained (right) images of bone tissue with muscle 
and marrow from an E2A-Cre positive mouse. The fluorescent image shows red fluorescence in 
muscle, and bone cells such as osteocytes, osteoblasts and osteoclast. The marrow shows blue 
color with DAPI staining. The toluidine blue stained image shows the marrow, bone matrix and 
muscle in purple color. 
 
 
 
Fluorescence                                           White light (toluidine blue) 
 
Figure 6: Microscopic images of bone tissue from an E2A-Cre positive mouse (without 
DAPI). Fluorescent (left) and toluidine blue stained (right) images of bone tissue with muscle and 
marrow from an E2A-Cre positive mouse. The fluorescent image shows red fluorescence in 
muscle and bone cells such as osteocytes, osteoblasts and osteoclast. The toluidine blue stained 
image shows the marrow, bone matrix and muscle in purple color. 
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Fluorescence                                               White light (toluidine blue) 
 
Figure 7: Microscopic images of bone tissue from an E2A-Cre negative mouse. Fluorescent 
(left) and toluidine blue stained (right) images of bone tissue with muscle and marrow from an 
E2A-Cre negative mouse. In the fluorescent image, the cell nuclei show blue color with DAPI 
staining. The toluidine blue stained image shows the marrow, bone matrix and muscle in purple 
color.  
 
3.4. Fluorescent microscopic analysis and qualitative results of the soft 
organs/ tissues from the E2A-Cre mice: 
To determine if there is Cre-mediated recombination in the soft tissues of E2A-
Cre mouse line, the Ai9 mice were crossed to the E2A-Cre mice. The double 
positive (Ai9+/E2A-Cre+) offspring were perfused and 5 um thick sections of soft 
tissues were prepared for histological analysis. The tissue sections were stained 
with DAPI. Figure 8-19 show the fluorescent (left) and toluidine blue stained 
(right) microscopic analysis results of both positive and negative soft tissues from 
the E2A-Cre mice. The E2A-Cre positive mice show significantly strong red 
fluorescence in majority of the cells in the tested soft tissues such as heart, 
kidney, liver, brain, duodenum and spleen. The negative control mice show no 
red fluorescent in any of the tissues. The nuclei appear as blue color with DAPI 
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staining. The results indicate that Ai9 mouse is successful as a reporter line to 
study Cre-mediate recombination in all the tested soft tissues. 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 8: Microscopic images of heart tissue from an E2A-Cre positive mouse. Fluorescent 
(left) and toluidine blue stained (right) images of heart tissue from an E2A-Cre positive mouse. In 
the fluorescent image, the heart cells appear as red color with Cre-expression and the nuclei as 
blue with DAPI staining. The cells appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                               White light (toluidine blue) 
 
Figure 9: Microscopic images of heart tissue from an E2A-Cre negative mouse.  
Fluorescent (left) and toluidine blue stained (right) images of heart tissue from an E2A-Cre 
negative mouse. The blue color in the fluorescent image is nuclei with DAPI staining. The cells 
appear in purple color the toluidine blue stained image. 
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Fluorescence                                               White light (toluidine blue) 
 
Figure 10: Microscopic images of kidney tissue from an E2A-Cre positive mouse.  
Fluorescent (left) and toluidine blue stained (right) images of kidney tissue from an E2A-Cre 
positive mouse. In the fluorescent image, the kidney cells show red color with Cre-expression and 
the nuclei appears as blue with DAPI staining. The cells appear in purple color in the toluidine 
blue stained image. 
 
 
Fluorescence                                               White light (toluidine blue) 
 
Figure 11: Microscopic images of kidney tissue from an E2A-Cre negative mouse.  
Fluorescent (left) and toluidine blue stained (right) images of kidney tissue from an E2A-Cre 
negative mouse. The blue color in the fluorescent image is nuclei with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                White light (toluidine blue) 
 
Figure 12: Microscopic images of liver tissue from an E2A-Cre positive mouse. Fluorescent 
(left) and toluidine blue stained (right) images of liver tissue from an E2A-Cre positive mouse. In 
the fluorescent image, the liver cells show red color with Cre expression and the nuclei appear as 
blue with DAPI staining. The cells appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 13: Microscopic images of liver tissue from an E2A-Cre negative mouse.  
Fluorescent (left) and toluidine blue stained (right) images of liver tissue from an E2A-Cre 
negative mouse. The blue color in the fluorescent image is nuclei with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 14: Microscopic images of brain tissue from an E2A-Cre positive mouse.  
Fluorescent (left) and toluidine blue stained (right) images of brain tissue from an E2A-Cre 
positive mouse. In the fluorescent image, the brain cells show red color with Cre-expression and 
the nuclei appear as blue with DAPI staining. The cells appear in purple color in the toluidine blue 
stained image. 
 
 
Fluorescence                                                white light (toluidine blue) 
 
Figure 15: Microscopic images of brain tissue from an E2A-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of heart tissue from an E2A-Cre 
negative mouse. The blue color in the fluorescent image is nuclei with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                White light (toluidine blue) 
 
Figure 16: Microscopic images of duodenum tissue from an E2A-Cre positive mouse.  
Fluorescent (left) and toluidine blue stained (right) images of duodenum tissue from an E2A-Cre 
positive mouse. In the fluorescent image, the cells show red color with Cre expression and the 
nuclei appear as blue with DAPI staining. The cells appear in purple color in the toluidine blue 
stained image. 
 
 
Fluorescence                                                  White light (toluidine blue) 
 
Figure 17:  Microscopic images of duodenum tissue from an E2A-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of duodenum tissue from an E2A-Cre 
negative mouse. Blue color in the fluorescent image is nuclei with DAPI staining. The cells appear 
in purple color in the toluidine blue stained image. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 18: Microscopic images of spleen tissue from an E2A-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of spleen tissue from an E2A-Cre 
positive mouse. In the fluorescent image, the spleen cells show red color with Cre expression and 
the nuclei appear as blue with DAPI staining. The cells appear in purple color in the toluidine blue 
stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
  
Figure 19: Microscopic images of spleen tissue from an E2A-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of spleen tissue from an E2A-Cre 
negative mouse. The blue color in the fluorescent image is nuclei with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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3.5. PCR result indicating the presence of DMP1-Cre transgene: 
PCR was performed with ear tissue samples from the offspring of the breeders - 
DMP1-Cre female and Ai9 male to detect the presence of DMP1-Cre transgene, 
using the respective primers. The gel was analyzed for the presence of 529 bp 
band of DMP1-Cre transgene and 1000bp band of connexin-43 internal control.  
Figure 20 shows PCR followed by agarose gel electrophoresis from DMP1-Cre 
mice tissue.  
 
 
Figure 20: Agarose gel showing the DMP1-Cre band. The first lane shows the DNA ladder. 
The second lane is a positive sample which shows 2 bands. The high band is internal control 
Connexin-43 that aligns with 1000bp band of the ladder and the low band is DMP1-Cre that align 
with 500bp band of the ladder. The third lane shows a negative sample which has only the 
internal control Connexin-43 band that aligns with 1000 bp band of the ladder.  
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3.6. Fluorescent microscopic and qualitative analysis results of the bone 
tissues from the DMP1-Cre mice: 
To determine if there is Cre-mediated recombination in the bone tissue of DMP1-
Cre mouse line, the Ai9 mice were crossed to the DMP1-Cre mice. The double 
positive (Ai9+/DMP1-Cre+) offspring were perfused and 5 um thick sections of 
the femur bone tissue were prepared for histological analysis. The bone tissue 
sections were stained with DAPI. Images 21a and 21b show fluorescent 
microscopic images (left) and toluidine blue stained white light images (right) of 
bone tissue from a DMP1-Cre positive mouse. The fluorescent images show 
bright red fluorescence in the osteocytes, and osteoblast residing in the newly 
forming bones. The skeletal muscle also shows strong red fluorescence in 
majority of their cells. Images 22a, 22b and 22c show fluorescent (left) and 
toluidine blue stained (right) images of the bone tissues from the DMP1-Cre 
positive mice without DAPI nuclear staining. The images show red fluorescence 
in osteocytes and osteoblasts. In addition, the muscle tissue shows strong red 
fluorescent expression. Image 23 shows the fluorescent and white light images of 
bone tissue from DMP1-Cre negative control mouse. There is no red 
fluorescence in DMP1-Cre negative mouse and the nuclei is visible as blue color 
with DAPI staining. 
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Fluorescent                                                    White light (toluidine blue) 
 
Figure 21a: Microscopic images of bone tissue from a DMP1-Cre positive mouse (DAPI 
stained). Fluorescent (left) and toluidine blue stained (right) images of a bone tissue with muscle 
and marrow from a DMP1-Cre positive mouse. The fluorescent image shows red fluorescence in 
the muscle and osteocytes. The osteoblasts show red color in the newly forming bone located in 
the marrow. The marrow shows blue color with DAPI staining. The toluidine blue stained image 
shows the marrow, bone cells and muscle in purple color. 
 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 21b: Microscopic images of bone tissue from a DMP1-Cre positive mouse (DAPI 
stained). Fluorescent (left) and toluidine blue stained (right) images of a bone tissue with muscle 
and marrow from a DMP1-Cre positive mouse. The fluorescent image shows red fluorescence in 
the muscle cells, osteoblasts and osteocytes. The osteoblasts show red color in the newly 
forming bone tissue located in marrow. The marrow shows blue colored DAPI stained nuclei and 
a few Cre positive red cells. The toluidine blue stained image shows the marrow, bone cells and 
muscle in purple color. 
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Fluorescence                                                White light (toluidine blue) 
 
Figure 22a: Microscopic images of bone tissue from a DMP1-Cre positive mouse (without 
DAPI).  Fluorescent (left) and toluidine blue stained (right) images of a bone tissue with muscle 
and marrow from a DMP1-Cre positive mouse. The fluorescent image shows red fluorescence in 
the muscle cells, osteoblasts and osteocytes. The osteoblasts show red color in the newly 
forming bone tissue located in the marrow. The marrow shows a few Cre positive red cells. The 
toluidine blue stained image shows the marrow, bone matrix and muscle in purple color. 
 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 22b: Microscopic images of bone tissue from a DMP1-Cre positive mouse (without 
DAPI). Fluorescent (left) and toluidine blue stained (right) images of a bone tissue with muscle 
and marrow from a DMP1-Cre positive mouse. The fluorescent image shows red fluorescence in 
the muscle cells, osteoblasts and osteocytes. The marrow shows a few Cre positive red cells. 
The toluidine blue stained image shows the marrow, bone cells and muscle in purple color. 
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Fluorescence                                               White light (toluidine blue) 
 
Figure 22C: Microscopic images of bone tissue from a DMP1-Cre positive mouse (without 
DAPI). Fluorescent (left) and toluidine blue stained (right) images of a bone tissue with muscle 
and marrow from a DMP1-Cre positive mouse. The fluorescent image shows red fluorescence in 
the muscle cells, osteoblasts and osteocytes. The marrow shows a few Cre positive red cells. 
The toluidine blue stained image shows the marrow, bone cells and muscle in purple color 
 
 
Fluorescence                                                White light (toluidine) 
 
Figure 23: Microscopic images of bone tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of a bone tissue with muscle and 
marrow from a DMP1-Cre negative mouse. In the fluorescent image the cell nuclei show blue 
color with DAPI staining. The toluidine blue stained image shows the marrow, bone cells and 
muscle in purple color. 
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3.7. Fluorescent microscopic and qualitative analysis results of the soft 
tissues from the DMP1-Cre mice: 
To determine if there is nonspecific Cre-mediated recombination in the soft 
tissues of DMP1-Cre mouse line, the Ai9 mice were crossed to the DMP1-Cre 
mice. The double positive (Ai9+/DMP1-Cre+) offspring were perfused and 5 um 
thick sections of different soft tissue such as heart, liver, kidney, spleen, 
duodenum and brain were prepared for histological analysis. The tissue sections 
were stained with DAPI. Figures 24 and 25 show fluorescent microscopic images 
(left) and toluidine blue stained white light images (right) of heart tissue from a 
DMP1-Cre positive and negative mouse respectively. Likewise, images 26-35 
show the microscopic images of different tissues such as liver, kidney, 
duodenum, brain and spleen from the DMP1-Cre positive and negative mice. The 
result shows that there is no red fluorescence in the brain, and spleen tissue of 
DMP1-Cre positive mice. A few cells in heart, kidney, duodenum and liver show 
red fluorescent cells. The DMP1-Cre negative mice show no red fluoresce 
expression in any of the tested tissues.   
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Fluorescence                                                white light (toluidine blue) 
 
 
Figure 24: Microscopic images of heart tissue from a DMP1-Cre positive mouse 
Fluorescent (left) and toluidine blue stained (right) images of heart tissue from a DMP1-Cre 
positive mouse. In the fluorescent image the DAPI stained nuclei appear as blue and a few 
cells shows red positive. The cells show purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                white light (toluidine blue)                        
 
 
Figure 25: Microscopic images of heart tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of heart tissue from a DMP1-Cre 
negative mouse. In the fluorescent image, the nuclei appears as blue with DAPI staining. Cells 
show purple color in the toluidine blue stained image 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 26: Microscopic images of kidney tissue from a DMP1-Cre positive mouse 
Fluorescent (left) and toluidine blue stained (right) images of kidney tissue from a DMP1-Cre 
positive mouse. In the fluorescent image, the nuclei appears as blue with DAPI staining and a few 
cells show red positive. The cells appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 27: Microscopic images of kidney tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of kidney tissue from a DMP1-Cre 
negative mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                  White light (toluidine blue) 
 
Figure 28: Microscopic images of liver tissue from a DMP1-Cre positive mouse. Fluorescent 
(left) and toluidine blue stained (right) images of liver tissue from a DMP1-Cre positive mouse. In 
the fluorescent image, the nuclei appear as blue with DAPI staining. The cells appear in purple 
color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
 
Figure 29: Microscopic images of liver tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of liver tissue from DMP1-Cre negative 
mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells appear 
in purple color in the toluidine blue stained image. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 30: Microscopic images of duodenum tissue from a DMP1-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of duodenum tissue from a DMP1-Cre 
positive mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining and a few 
cells show red positive. The cells appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
 
Figure 31: Microscopic images of duodenum tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of duodenum tissue from a DMP1-Cre 
negative mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 32: Microscopic images of brain tissue from a DMP1-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of brain tissue from a DMP1-Cre 
positive mouse. In the fluorescent image the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
 
Figure 33: Microscopic images of brain tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of brain tissue from a DMP1-Cre 
negative mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                               White light (toluidine blue) 
 
Figure 34: Microscopic images of spleen tissue from a DMP1-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of spleen tissue from a DMP1-Cre 
positive mouse. In the fluorescent image the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
 
Figure 35: Microscopic images of spleen tissue from a DMP1-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of spleen tissue from a DMP1-Cre 
negative mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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3.8. Results of quantitation of positive Cre-expressing cells in the bone and 
soft tissues of the DMP1-Cre mice by ImageJ cell counting:  
 
To study the effect of Cre-mediated recombination in the tissues of DMP1-Cre 
mouse line, fluorescence microscopic analysis of 5um thick sections of the femur 
bone and soft tissues from the double positive (Ai9+/DMP1-Cre+) mice was 
performed. The tissue sections were analyzed for positive red color fluorescence 
which is an indication of Cre-recombinase. Fluorescence positive cells were 
quantitated using ImageJ software program. The total number of cells were 
counted using ImageJ automated counting tool and the red positive cells in each 
positive Cre-expressing tissue samples were counted manually. The result of the 
cell quantitation from the positive Cre-expressing tissue are listed in Table 2. 
 
The average of percentage of the Cre-expression from the studied three mice 
and their standard deviations are listed in Table 3.   
 
Figure 36 is a Bar chart showing Cre recombinase expression in the bone and all 
tested soft tissues from the three DMP1-Cre mice used in this study. 
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Table 2: Cell quantitation result from the different tissues of the three DMP1-Cre mice used in this 
study. 
 
 
 
 
 
 
 
 
 
Total 
number of 
cells
Number of 
positive 
cells
Total 
number of 
cells
Number of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Sample1 3082 12 61 41 1101 1 2710 0 1775 87
Sample2 7034 4 83 72 1064 0 2405 17 1035 16
Sample3 2965 34 51 43 1036 0 2330 0 2154 173
Sample1 2977 41 87 79 1252 0 2859 17 1733 61
Sample2 3944 47 98 87 1583 7 2115 22 1609 112
Sample3 2709 12 129 104 1528 4 2611 4 1114 56
Sample1 3288 5 62 55 897 2 2607 10 2859 61
Sample2 3609 0 43 36 1218 13 2049 10 2115 62
Sample3 4369 1 55 50 1243 10 8328 0 2611 40
Duodenum
DMP-Cre
Mouse 1
Mouse 2
Mouse 3
Bone marrow KidneyOsteocytes Heart
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Table 3: Result of quantitation of positive Cre-expression and its standard deviation from the 
different tissues of the three DMP1-Cre mice used in this study. 
 
 
 Bone marrow Osteocytes heart kidney liver brain Duodenum Spleen 
Mouse 1 sample
1 0.4 83.6 0.09 0 0.18 0 4.9 0
2 0.01 86.8 0 0.71 0 0 1.55 0
3 1.15 84.3 0 0 0.075 0 8.03 0
Average 0.52 84.9 0.03 0.23667 0.085 0 4.8266667 0
Standard 
deviation 0.579396237 1.68226038 0.05196 0.40992 0.09042 0 3.2406224 0
Mouse 2 sample
1 1.38 90.8 0 0.59 0 0 3.52 0
2 1.19 88.8 0.44 1.04 0 0 6.95 0
3 0.44 80.6 0.26 0.15 0.43 0 5.03 0
Average 1.003333333 86.7333333 0.23333 0.59333 0.14333 0 5.1666667 0
Standard 
deviation 0.49702448 5.40493602 0.22121 0.44501 0.24826 0 1.7190792 0
Mouse 3 Sample
1 0.15 88.8 0.22 0.38 0 0 0.03 0
2 0 83.7 1.08 0.49 0 0 0.3 0
3 2.3 90.9 0.8 0 0 0 0.1 0
Average  87.8 0.7 0.29 0 0 0.1433333 0
Standard 
deviation 1.286791876 3.70270172 0.43863 0.2571 0 0 0.140119 0
% of Cre exprssion in DMP1-Cre mice tissues[ ( number of positive cell/Total number of 
cells) X 100]
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Figure 36: Bar chart showing percentage of Cre recombinase expression from the different 
tissues of the three DMP1-Cre mice used in this study. 
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3.9. PCR results indicating the presence of Ctsk-Cre transgene: 
PCR was performed with ear tissue samples from the offspring of the breeders -   
Ctsk-Cre female and Ai9 male to detect the presence of Ctsk-Cre transgene, 
using the respective primers. The gel was analyzed for the presence of 600 bp 
band of Ctsk-Cre transgene and 1000bp band of connexin-43 internal control. 
Figure 37 shows PCR followed by agarose gel electrophoresis from Ctsk-Cre 
mice tissue.  
 
 
Figure 37: Agarose gel showing Ctsk-Cre band. The first lane shows the DNA ladder. The 
second lane is a positive sample which shows 2 bands. The high band is internal control 
Connexin-43 that aligns with 1000bp band of the ladder and the low 600bp band is Ctsk-Cre. The 
third lane shows a negative sample which shows only the internal control Connexin-43.  
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3.10. Fluorescence microscopic and qualitative analysis results of the bone 
tissues from the Ctsk-Cre mice: 
To determine if there is Cre-mediated recombination in the bone tissue of Ctsk-
Cre mouse line, the Ai9 mice was crossed to the Ctsk-Cre mice. The double 
positive (Ai9+/Ctsk-Cre+) offspring were perfused and 5 um thick sections of the 
femur bone tissue were prepared for histological analysis. The bone tissue 
sections were stained with DAPI. Figures 38a and 39a show fluorescent 
microscopic images (left) and toluidine blue stained white light images (right) of 
bone tissue from a Ctsk-Cre positive mouse. Red fluorescent osteoclasts 
residing on the bone surface, appearing with ruffled borders, can be seen. Some 
of the osteocytes in the bone matrix, and a few cells in the marrow also show red 
fluorescence which can be quantitated. There is no Cre-expression in muscle 
tissue. Figures 38b and 39b show bone tissue from a Ctsk-Cre mouse without 
DAPI nuclear stain, which also yielded strong positive fluorescence in 
osteoclasts. Figures 40 and 41 of the bone marrow show red fluorescence in a 
few cells residing on bone surface, which indicates Cre-expression in osteoclasts 
(Cathepsin K). Figure 42 (reproduced from Reference 27) shows H&E stained 
bone tissue. The brown color on the surface indicates Cathepsin K localization in 
osteoclasts. Figure 43 shows newly forming bone with osteoblasts and 
osteocytes which shows no red fluorescence, supporting the lack of Cre- 
expression in osteoblasts and osteocytes. Figure 44 shows bone tissue from a 
Ctsk-Cre negative control mouse which yielded no red fluorescence in bone, 
marrow and muscle cells. The microscopic qualitative analysis of bone tissue 
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from Ctsk-Cre positive mice show that there is significant Cre-expression in 
osteoclasts. There are a few red positive cells in marrow and osteocytes.  
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 38a: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
positive mouse (DAPI stained). Fluorescent (left) and toluidine blue stained (right) images of 
bone tissue with muscle and marrow from a Ctsk-Cre positive mouse. The fluorescent image 
shows red fluorescence in osteoclasts located on the bone surface. A few osteocytes on in the 
matrix show positive expression. The marrow shows blue color with DAPI nuclear staining. The 
toluidine blue stained image shows the marrow, bone matrix and muscle in purple color. 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 38b: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
positive mouse (without DAPI). Fluorescent (left) and toluidine blue stained (right) images of 
bone tissue with muscle and marrow from a Ctsk-Cre positive mouse. The fluorescent image 
shows red fluorescence in osteoclasts located on the bone surface. A few osteocytes on the 
matrix show positive red.The toluidine blue stained image shows the marrow, bone matrix and 
muscle in purple color. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 39a: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
positive mouse (DAPI stained).  Fluorescent (left) and toluidine blue stained (right) images of 
bone tissue with muscle and marrow from a Ctsk-Cre positive mouse. The fluorescent image 
shows red fluorescence in osteoclasts located on the bone surface. A few osteocytes in the 
matrix show red positive. The marrow shows blue color with DAPI nuclear staining. The toluidine 
blue stained image shows the marrow, bone matrix and muscle in purple color. 
 
 
Fluorescence                                               White light (toluidine blue) 
 
Figure 39b: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
positive mouse (without DAPI). Fluorescent (left) and toluidine blue stained (right) images of 
bone tissue with muscle and marrow from a Ctsk-Cre positive mouse. The fluorescent image 
shows red fluorescence in osteoclasts located on the bone surface. The marrow shows blue color 
with DAPI nuclear staining. The toluidine blue stained image shows the marrow, bone matrix and 
muscle in purple color. 
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Fluorescence                                                  White light (toluidine blue) 
 
Figure 40a: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
positive mouse (DAPI stained). Fluorescent (left) and toluidine blue stained (right) images of 
bone tissue with marrow from a Ctsk-Cre positive mouse. The fluorescent image shows red 
fluorescence in osteoclasts located on the bone surface. The marrow shows blue color with DAPI 
nuclear staining. The toluidine blue stained image shows the marrow, bone matrix and muscle in 
purple color. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 40b: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
positive mouse (without DAPI). Fluorescent (left) and toluidine blue stained (right) images of 
bone tissue with marrow from a Ctsk-Cre positive mouse. The fluorescent image shows red 
fluorescence in osteoclasts located on the bone surface. The toluidine blue stained image shows 
the marrow, bone matrix and muscle in purple color. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 41: Microscopic images of bone tissue with marrow from a Ctsk-Cre positive 
mouse. Fluorescent (left) and toluidine blue stained (right) images of bone tissue with marrow 
from a Ctsk-Cre positive mouse. The red color dots on the surface indicate the presence of 
osteoclasts. The marrow shows blue color with DAPI nuclear staining. The toluidine blue stained 
image shows the marrow, bone matrix and muscle in purple color. 
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Figure 42: Cathepsin K localization in osteoclast (reference 27). H&E stained bone tissue. The 
brown color on the bone surface indicates Cathepsin K localized in osteoclasts. 
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Fluorescence                                                   White light (toluidine blue)   
 
Figure 43: Microscopic images of bone tissue from a Ctsk-Cre positive mouse (osteoblasts 
and osteocytes). Bone marrow with newly forming bone tissue from a Ctsk-Cre positive mouse. 
Absence of red color in the fluorescent image supports that there is no Cre-expression in 
osteoblast or osteocytes. The marrow appears as blue with DAPI nuclear staining. The toluidine 
blue stained image shows marrow in purple color. 
 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 44: Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
negative mouse. Microscopic images of bone tissue with marrow and muscle from a Ctsk-Cre 
negative mouse Fluorescent (left) and toluidine blue stained (right) images of bone tissue with 
muscle and marrow from a Ctsk-Cre negative mouse. In the fluorescent image the cell nuclei give 
blue color with DAPI staining. The toluidine blue stained image shows the marrow, bone matrix 
and muscle in purple color. 
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3.11. Fluorescence microscopic and qualitative analysis results of the soft 
tissues from the Ctsk-Cre mice: 
To determine if there is nonspecific Cre-mediated recombination in the soft 
tissues of Ctsk-Cre mouse line, the Ai9 mice were crossed to the Ctsk-Cre mice. 
The double positive (Ai9+/Ctsk-Cre+) offspring were perfused and 5 um thick 
sections of the tissue such as heart, kidney, liver, brain, duodenum and spleen 
were prepared for histological analysis. The tissue sections were stained with 
DAPI.  Figures 45 and 46 show fluorescent microscopic images (left) and 
toluidine blue stained white light images (right) of heart tissue from a Ctsk-Cre 
positive and negative mouse respectively. Likewise, figures 47-55 show the 
microscopic images of different soft tissues such as liver, kidney, duodenum, 
brain and spleen from the Ctsk-Cre positive and negative mice. The result shows 
that there is no Cre-expression in duodenum and spleen cells of Ctsk-Cre 
positive mouse. A few cells in kidney, liver and heart tissues show red 
fluorescence. However, brain tissue yielded significant red fluorescence. All the 
tested soft tissues from negative control Ctsk-Cre mice show negative 
fluorescence. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 45: Microscopic images of heart tissue from a Ctsk-Cre positive mouse. Fluorescent 
(left) and toluidine blue stained (right) images of heart tissue from a Ctsk-Cre positive mouse. In 
the fluorescent image, the nuclei appear as blue with DAPI staining. The cells appear in purple 
color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
 
Figure 46: Microscopic images of heart tissue from a Ctsk-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of heart tissue from a Ctsk-Cre 
negative mouse. In the fluorescent image, the nuclei appears as blue with DAPI staining. The 
cells appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 47: Microscopic images of kidney tissue from a Ctsk-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of kidney tissue from a Ctsk-Cre 
positive mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining and a few 
cells shows red positive. The cells appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 48: Microscopic images of kidney tissue from a Ctsk-Cre negative mouse.  
Fluorescent (left) and toluidine blue stained (right) images of kidney tissue from a Ctsk-Cre 
negative mouse. In the fluorescent image, nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image 
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Fluorescence                                                 White light (toluidine blue) 
 
Figure 49: Microscopic images of liver tissue from a Ctsk-Cre positive mouse.  Fluorescent 
(left) and toluidine blue stained (right) images of liver tissue from a Ctsk-Cre positive mouse. In 
the fluorescent image, the nuclei appears as blue with DAPI staining and a few cells shows red 
positive. The cells appear in purple color in the toluidine blue stained image 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 50: Microscopic images of liver tissue from a Ctsk-Cre negative mouse. Fluorescent 
(left) and toluidine blue stained (right) images of liver tissue from a Ctsk- Cre negative mouse. In 
the fluorescent image, the nuclei appears as blue with DAPI staining. The cells appear in purple 
color in the toluidine blue stained image. 
 
 
 
 
  
59 
 
Fluorescence                                               White light (toluidine blue) 
 
Figure 51a: Microscopic images of brain tissue from a Ctsk-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of brain tissues from a Ctsk-Cre 
positive mouse. The fluorescent images show bright red color since the entire cells have turned 
into red with positive Cre-expression. The nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                White light (toluidine blue) 
 
Figure 51b: Microscopic images of brain tissue from a Ctsk-Cre positive mouse.  
Fluorescent (left) and toluidine blue stained (right) images of brain tissues from a Ctsk-Cre 
positive mouse. The fluorescent images show bright red color since the entire cells have turned 
into red with positive Cre expression. The nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                White light (toluidine blue) 
 
Figure 52: Microscopic images of brain tissue from a Ctsk-Cre negative mouse.  
Fluorescent (left) and toluidine blue stained (right) images of brain tissue from a Ctsk-Cre 
negative mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                White light (toluidine blue) 
 
Figure 53: Microscopic images of duodenum tissue from a Ctsk-Cre positive mouse.  
Fluorescent (left) and toluidine blue stained (right) images of duodenum tissue from a Ctsk-Cre 
positive mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 54: Microscopic images of duodenum tissue from a Ctsk-Cre negative mouse.  
Fluorescent (left) and toluidine blue stained (right) images of duodenum tissue from a Ctsk-Cre 
negative mouse. In the fluorescent image, the nuclei appears as blue with DAPI staining. The 
cells appear in purple color in the toluidine blue stained image. 
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Fluorescence                                                 White light (toluidine blue) 
   
Figure 55: Microscopic images of spleen tissue from a Ctsk-Cre positive mouse. 
Fluorescent (left) and toluidine blue stained (right) images of spleen tissue from a Ctsk-Cre 
positive mouse. In the fluorescent image, the nuclei appear as blue with DAPI staining and a few 
cells shows red positive. The cells appear in purple color in the toluidine blue stained image. 
 
 
Fluorescence                                                 White light (toluidine blue) 
 
Figure 56: Microscopic images of spleen tissue from a Ctsk-Cre negative mouse. 
Fluorescent (left) and toluidine blue stained (right) images of spleen tissue from a Ctsk-Cre 
negative mouse. In the fluorescent image, nuclei appears as blue with DAPI staining. The cells 
appear in purple color in the toluidine blue stained image. 
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3.12. Results of quantitation of positive Cre-expressing cells in the bone 
and soft tissues of the Ctsk-Cre mice by ImageJ cell counting: 
 
To study the effect of Cre-mediated recombination in Ctsk-Cre mouse line, 
fluorescence microscopic analysis of 5um thick sections of the femur bone and 
soft tissues from the double positive (Ai9+/Ctsk-Cre+) mice was performed. The 
tissue sections were analyzed for positive red color fluorescence which is an 
indication of Cre recombinase. The total number of cells were counted using 
ImageJ automated counting tool and the red positive cells in each positive Cre- 
expressing tissue samples were counted manually. The result of the cell 
quantitation from positive Cre-expressing tissue are listed in table 4. 
 
The average of percentage of Cre-expression from the studied three Ctsk-Cre 
mice and its standard deviations are listed in table 5.   
 
Figure 57 is Bar chart showing Cre recombinase expression in bone and all 
tested soft tissues from the three Ctsk-Cre mice used in this study. 
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Table 4: Cell quantitation result from the different tissues of the three Ctsk-Cre mice used in this 
study. 
 
 
 
 
 
 
 
 
 
 
Total 
number 
of cells
Number 
of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Total 
number 
of cells
Number 
of 
positive 
cells
Sample1 4681 7 6 28 958 4 2700 2 1666 3
Sample2 8503 16 5 30 1655 0 3098 6 1118 0
Sample3 3526 9 8 33 838 1 2573 4 1325 1
Sample1 6499 5 2 37 1430 10 3504 6 1509 0
Sample2 4614 6 6 61 1412 15 3449 3 1633 0
Sample3 4738 0 5 67 1322 0 3432 1 1628 7
0
Sample1 1894 1 8 121 956 0 2981 0 1415 0
Sample2 4941 4 4 55 1196 0 2652 3 1313 0
Sample3 4941 3 4 41 951 0 2903 5 1401 0
Mouse 3
Bone marrow Osteocytes Heart Kidney
Mouse 1
Liver
Ctsk-Cre
Mouse 2
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Table 5: Result of quantitation of positive Cre-expression and its standard deviation from the 
different tissues of the three Ctsk-Cre mice used in this study. 
 
 
 
 
 
Bone marrow Osteocyte Heart Kidney Liver Brain Duodenum Spleen
sample
1 0.15 21.43 0.42 0.074 0.18 100 0 0
2 0.19 16.67 0 0.194 0 100 0 0
3 0.26 24.24 0.12 15.5 0.075 100 0 0
Average 0.2 20.78 0.18 5.256 0.085 100 0 0
Standared 
deviation 0.055677644 3.8266304 0.21633 8.87177 0.090416 0 0 0
sample
1 0.08 5.41 0.69 0.17 0 100 0 0
2 0.13 9.84 1.06 0.09 0 100 0 0
3 0 7.46 0 0.03 0.43 100 0 0
Average 0.07 7.57 0.58333 0.09667 0.143333 100 0 0
Standared 
deviation 0.065574385 2.2170476 0.53799 0.07024 0.248261 0 0 0
sample
1 0.05 6.61 0 0 0 100 0 0
2 0.081 7.27 0 0.11 0 100 0 0
3 0.071 9.76 0 0.17 0 100 0 0
Average 0.067333333 7.88 0 0.09333 0 100 0 0
Standared 
deviation 0.015821926 1.6612345 0 0.08622 0 0 0 0
Mouse3
% of Cre exprssion in Ctsk-Cre mice tissues[ ( number of positive cell/Total number of cells) X 
100]
Mouse1
Mouse 2
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Figure 57: Bar chart showing percentage of Cre recombinase expression from the different 
tissues of the three Ctsk-Cre mice used in this study. 
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4. Discussion and Conclusion 
In this study the tissue specificity and reliability of different bone cell-specific Cre 
mouse models were tested by crossbreeding them with the Ai9 Cre reporter 
mouse line. The bone and soft tissues of the offspring were screened for red 
fluorescent protein expression, which is the indication for Cre-mediated 
recombination. Though Cre mouse lines are valuable tools to study site-specific 
gene recombination in animal models, a literature review indicates that they can 
be expressed in off target cells [1]. For this reason, Cre mouse lines should be 
scrutinized for their reliability and selectivity for tissue specific recombination 
before they are used for actual gene deletion studies. No previous study has 
been done to determine the reliability and selectivity of bone-cell-specific Cre 
mouse models. Therefore, our lab was interested to examine them to determine 
if these Cre mouse models could be used for actual gene deletion experiments in 
bone tissue. Molecular and histological methods were applied to test the Cre-
expression in targeted bone cells and off targeted other soft tissues throughout 
the body of mouse. To accomplish this goal the Ai9 reporter was crossed to 
different bone cell specific Cre mouse lines. In order to test the efficiency of this 
reporter mouse in bone and soft tissues throughout the mouse body, they were 
crossed with a global Cre mouse line E2A which has a wide range of tissue 
target including bone and all type of soft tissues. DMP1-Cre mouse, where the 
Cre recombinase is driven by a 14kb fragment of the DMP1 promoter was tested 
to study its presumed specificity and reliability for late-stage osteoblasts and 
osteocytes. The tissue sections were examined for red fluorescence in their cells 
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and the positive cells were quantitated by means of ImageJ software. Likewise, 
the reliability and selectivity of Ctsk-Cre mouse lines were tested for targeted 
deletion in osteoclasts.  
 
4.1. Ai9 mouse as Cre reporter line:  
In order to test the efficiency and reliability of the Ai9 allele for studying the effect 
of Cre-mediated recombination in bone and soft tissues, the reporter mouse was 
crossbred with the E2A-Cre mouse, where E2A is a global promoter that has a 
wide range of tissue targets and drives the Cre recombinase to all type of cells in 
the mouse body. The double positive offspring (Ai9+/E2A+) were perfused and 
the bone and soft tissues were analyzed for fluorescence. The fluorescent 
microscopic analysis of bone tissue showed that osteocytes, osteoclasts and 
osteoblasts all fluoresced red. But bone marrow was negative in fluorescence 
which explains that Ai9 reporter protein is repressed in this compartment. The 
tested soft tissues such as heart, kidney, liver, spleen, duodenum and brain also 
showed strong red fluorescence in their cells. These results confirm that the Ai9 
transgene is capable of reporting recombination in all cell types except bone 
marrow. Thus, if we were to find a lack of fluorescence in our bone-specific Cre 
screen, we would be able to discount the explanation that the Ai9 was incapable 
of recombining in those particular cell types. In that sense, the E2A-Cre result 
serves as a positive control.   
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4.2. Effect of Cre-mediated recombination in the tissues of DMP1-Cre 
mouse line:  
DMP1 is a promoter specific for late stage osteoblasts and osteocytes and it 
drives Cre-expression only to these bone cell types. The DMP1-Cre mouse was 
crossbred with the Ai9 reporter mouse. The double positive (Ai9+/DMP1-Cre+) 
offspring were perfused and the femur bone and soft tissues such as heart, 
kidney, liver, brain, duodenum and spleen were analyzed under fluorescence 
microscopy for red fluorescent protein expression. Three mice samples of 4-6 
weeks old were analyzed. Cre-expression in each tissue was quantitated by 
counting the nuclei of cells of each tissue sample using ImageJ software. The 
fluorescent microscopic analysis of the bone tissue showed bright red color in the 
majority of osteocytes (85-88%), and osteoblasts. Marrow showed expression in 
only 0.5 to 1% of cells. Interestingly, the muscle tissue also showed bright red 
fluorescence in majority of its cells which cannot be quantitated by counting the 
total cells (nuclei) since muscle tissue is multi nucleated. There were no red 
fluorescent cells in the brain and spleen. There were a few positive cells 
expressing red fluorescence in other soft tissues, heart (0.03-0.7%), kidney 
(0.24-0.6%), liver (0-0.1%) and duodenum (0.14-5.2%) which is not sufficient to 
give any phenotypic effect. The results of the study show that DMP1-Cre is not a 
specific model to study gene deletion in osteoblast because of its off targeted 
expression in muscle tissue.  
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However, DMP1-Cre mouse line is the only available Cre model to target 
osteocytes. To make use of this model for actual gene deletion study in bone 
tissue, further experiments need to be designed with a mouse that harbors a 
promoter specific  only for muscle tissue (Muscle-Cre) so that the deletion can 
occur only in muscle. If the phenotypic effect of a deletion with muscle-Cre gives 
the same effect with that of Dmp1-Cre, it might indicates that the gene of interest 
has functional significance in muscle rather than bone. On the other hand, the 
red fluorescence in the muscle tissue does not necessarily indicate that there is 
DMP1-Cre expression in the muscle at the time of sacrifice. Certain genes are 
temporarily expressed and then diminish during the embryonic stage. There is a 
possibility that DMP1 gene is transiently expressed in the muscle during 
embryonic development, which would have lasting effects on all daughter cells. 
The cells remain red because the recombination of the mTomato allele is 
irreversible even after DMP1 expression is turned off. To investigate on this, we 
can make use of a next generation of Cre model in which the timing of Cre 
activity in nucleus can be controlled. This is accomplished by fusing the Cre 
protein with an estrogen receptor mutant protein. The estrogen receptor portion 
of the fusion protein sequesters the protein in the cytosol, away from the nucleus.  
Consequently, no Cre-DNA activity occurs. However, when the cell is exposed to 
the estrogen analog tamoxifen, the fusion protein is stimulated to translocate to 
the nucleus, where it can exert its recombination activity [2, 11]. Our lab is 
interested to conduct a future study with these mice that harbor this Cre-estrogen 
mutant protein—called CreERt2—driven by the Dmp1 promoter (osteocyte 
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selective) in conjunction with the Ai9 reporter, to assess whether the expression 
in muscle cell is limited to embryonic stage of DMP1-Cre mouse.   
 
4.3. Effect of Cre-mediated recombination in the tissues of Ctsk-Cre mouse 
line: 
Ctsk is a promoter specific for osteoclasts and it presumably drives Cre-
expression only tin osteoclasts. The Ctsk-Cre mouse was cross bred with the Ai9 
reporter mouse. The double positive (Ai9+/Ctsk-Cre+) offspring were perfused 
and the femur bone and soft tissues such as heart, kidney, liver, brain, 
duodenum and spleen were analyzed under fluorescent microscope for red 
fluorescent expression. Three mice samples of 4-6 weeks old were analyzed.  
Cre-expression in each tissue was quantitated by counting the nuclei of cells of 
each tissue sample using ImageJ software. The fluorescent microscopic analysis 
of the bone tissue showed bright red color on cells on the bone surface where 
osteoclasts are located. However it is not possible to quantitate total number of 
osteoclasts present in each sample since they are multinucleated and it is difficult 
to identify them. A surprising number of osteocytes expressed the fluorescent 
protein (7-20.1%). Marrow showed expression in only 0.07- to 0.2% of its cells. 
There were no red fluorescent cells in duodenum and spleen. There were very 
few number of cells expressed in other soft tissues, heart (0 – 0.5%), kidney 
(0.09 – 5.3%), liver (0 – 0.1%), which is not sufficient to give any phenotypic 
effect. However, this study has revealed that Ctsk-Cre is expressed in brain 
since100% of the brain cells were turned to bright red color. The results of is 
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study shows that Ctsk-Cre is not a specific model to study gene deletion in 
osteoclasts because of its nonspecific expression in brain tissue.  
 
Trap-Cre is another mouse model available to target gene deletion in osteoclasts 
which needs to be tested in similar way. To make use of Ctsk-Cre for actual gene 
deletion study in bone tissue, further experiments need to be designed with a 
mouse that harbor a promoter specific  only for brain tissue (brain-Cre) so that 
the deletion occurs only in brain. If the phenotypic effect of a deletion with ‘brain-
Cre’ gives the same effect with that of ‘bone-Cre’, it implies that the gene of 
interest has functional significance in brain. 
 
As previously explained, the red fluorescence in the brain tissue does not 
necessarily indicate that there is Ctsk-Cre expression in the brain at the time of 
sacrifice. It could be the transient expression of Ctsk gene in brain during 
embryonic development, which would have lasting effects on all daughter cells. 
However, the cells remain red because the recombination of the mTomato allele 
is irreversible even after Ctsk expression is turned off. To investigate this, a next 
generation of Cre model Ctsk-Cre-ERt2 has to be constructed since this mouse 
model has not been constructed the moment.   
 
This study has revealed that DMP1 gene is expressed in muscle tissue and Ctsk 
gene is expressed in brain tissue of the respective Cre mouse lines though it is 
not certain whether the expression is limited to the embryonic developmental 
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stage. It has opened vast areas for further research such as whether these 
genes are expressed in postnatal life, if so, what are the functional roles of these 
genes in those expressed soft tissues. If these questions are answered, these 
bone cell specific Cre mouse models can still be utilized to delete and study a 
gene of interest in bone cells.  
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